Press Room

Press Clipping / Feb 18, 2018

Invest in talent to find future leaders

The Sunday Times, February 18, 2018

Smart companies are focusing on internal training schemes to develop and mentor graduate employees.

The challenge of attracting the right people in a highly competitive recruitment market is leading many organisations to consider developing their own talent from within. While formal graduate programmes are nothing new in larger organisations, such schemes are becoming more common at smaller companies.

Recruitment firm Fastnet, which has offices in Cork and Dublin, has been successful at developing its own talent rather than hiring from competitors over the past 15 or 20 years, according to managing partner Niamh O’Driscoll. She said a formal graduate programme that brings people into the company at a very early stage was the next logical step.

The first two graduates- one with a psychology degree and the other with a biochemistry background- have been taken on for the two year rotational programme. After six months getting to grips with all aspects of Fastnet’s business, the new hires will work in the talent acquisition division, focused initially on quality and laboratory, and then on engineering.

“We have a very specific methodology and core values”, said O’ Driscoll. “The programme allows us to instil our values from the beginning and will help ensure there is a consistent pipeline of quality talent coming up”.

Portuguese pharmaceutical company Hovione, which has a contract manufacturing site in Cork that employs more than 200 people, has also been looking at innovative ways of developing talent.

“We’re quite a small company so we’re not going to have a huge internal mentoring or graduate recruitment programme” said human resources director Mary Hennessy. “We’ve tried to align with international programmes where we can facilitate one or two graduates.”

INOV Contacto, is an EU-funded scheme that enables young Portuguese’s workers to work abroad for six months as interns in multinational companies. In Hovione’s case, the candidates typically have a master’s degree or a PHD in chemistry.

“At the end of the placement it’s up to us if we want to offer a full-time position” said Hennessy. “Both of the participants so far have stayed with us and relocated to Cork as process engineers”.

The company also participates in the Ibec Global Graduates Programme, taking on two people through this route each year. The 12 month programme involves six months working with the Cork team and six months based in one of the other Hovione sites in Lisbon, New Jersey or Macau. The company has gone on to hire six graduates through this programme.

Read Article

 

Also in the Press Room

See All

Aim to accelerate drug development and production with new technologies. By: Charlie Sternberg Hovione, an international integrated pharmaceutical development and manufacturing organization, and Microinnova Engineering, a leader in continuous process intensification, have partnered to advance the development of multi-purpose, plug-and-play modular equipment for flow chemistry. The companies will work together to test Microinnova’s modular manufacturing equipment, which is designed to offer greater flexibility, easier scalability, enhanced efficiency, and sustainable practices in active ingredient production, in an industrial setting. Together, the companies aim to accelerate process development, facilitate a seamless transition from lab to large-scale manufacturing, and ultimately reduce the time to market for pharmaceutical customers. “This collaboration with Microinnova underscores Hovione’s commitment to innovation in pharmaceutical manufacturing, with flow chemistry playing an important role in our long-term drug substance strategy,” said Dr. Jean-Luc Herbeaux, CEO of Hovione. “This partnership will allow us to shape and validate emerging continuous manufacturing technologies, which can potentially accelerate drug development and production.” Dr. Dirk Kirschneck, Founder and Strategic Director at Microinnova, added, “This partnership reflects our shared vision to deliver modular manufacturing technologies that support pharmaceutical innovation and manufacturing excellence. We are proud to join forces with Hovione to showcase the capabilities of our next-generation modular equipment in a dynamic CDMO environment, demonstrating its versatility for multi-purpose manufacturing.”   Read the full article on ContractPharma.com  

Press Clipping

Hovione, Microinnova Partner to Test Modular Manufacturing Equipment

Sep 24, 2025

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025